News

The Indian genomics market is projected to grow by 18% in the next five years, driven by the decreasing costs of tests and increased affordability for the middle class and above. This growth aligns with the global genomics market,...

World Health Organization, partners are going ahead with the launch of a global network that will help protect people from infectious disease threats by way of pathogen genomics. The International Pathogens Surveillance Network will go on to provide a platform...

The European Medicine Agency's (EMA) new published document has gone on to make ten recommendations and has also sketched out good practises to make sure of continuity when it comes to the supply of medicines for humans, safeguard the...

uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene therapy (CGT) CDMO...

Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems. QS-21 is used in several innovative vaccines against diseases such...

Powder transfer specialist, ChargePoint Technology has joined forces with sampling device specialist, Famat Sampling, to tackle one of the industry’s most challenging containment problems. The pharmaceutical suppliers have created an integrated valve solution capable of allowing operators to take...

Lower valuations can benefit acquirers in 2023, but IPOs and venture funding are expected to be slow. To address valuation challenges, the biopharma sector must prioritize clinical successes this year, particularly in areas such as respiratory syncytial virus, Alzheimer's...